公开(公告)号：US20200276157A1

公开(公告)日：2020-09-03

申请号：US16877484

申请日：2020-05-18

Applicant: David Weinstein Consulting, Inc.

Inventor： David Weinstein

IPC: A61K31/40 ,  A61K31/506 ,  A61K38/13 ,  A61K31/17 ,  A61K31/401

Abstract: The present invention is directed to a composition for treating alopecia containing minoxidil, cyclosporine A and a compound that binds FK506 binding protein 4 suitable for administration to humans. The present invention is further directed to treating alopecia in humans by administering a composition of the invention.

公开(公告)号：US20200276158A1

公开(公告)日：2020-09-03

申请号：US16877485

申请日：2020-05-18

Applicant: David Weinstein Consulting, Inc.

Inventor： David Weinstein

IPC: A61K31/401 ,  A61K38/13 ,  A61K31/506 ,  A61K31/40 ,  A61K47/10 ,  A61K47/18 ,  A61K47/14 ,  A61K47/12 ,  A61K47/02 ,  A61K9/00 ,  A61K47/06 ,  A61K47/26 ,  A61K47/32 ,  A61K47/34 ,  A61K9/08

Abstract: The present invention is directed to a composition for treating alopecia containing minoxidil, cyclosporine A and a compound that binds FK506 binding protein 4 suitable for administration to humans. The present invention is further directed to treating alopecia in humans by administering a composition of the invention.

公开(公告)号：US20180140576A1

公开(公告)日：2018-05-24

申请号：US15848594

申请日：2017-12-20

Applicant: David Weinstein Consulting, Inc.

Inventor： David Weinstein

IPC: A61K31/40 ,  A61K9/00 ,  A61K47/44 ,  A61K9/06 ,  A61K38/13

CPC classification number: A61K31/40 ,  A61K9/0014 ,  A61K9/06 ,  A61K38/13 ,  A61K47/44

Abstract: The present invention is related to a compound of formula (I) or a pharmaceutically acceptable salt or ester thereof. The present invention is further related to a method of healing and/or inhibiting formation of scar tissue in an external wound of a subject comprising topically administering to the external wound of the subject an effective amount of a compositing containing a compound that binds FK506 binding protein 4.

公开(公告)号：US20190216777A1

公开(公告)日：2019-07-18

申请号：US16358781

申请日：2019-03-20

Applicant: David Weinstein Consulting, Inc.

Inventor： David Weinstein

IPC: A61K31/401 ,  A61K47/02 ,  A61K47/12 ,  A61K9/00 ,  A61K47/14 ,  A61K47/18 ,  A61K47/10 ,  A61K31/40 ,  A61K31/506 ,  A61K38/13 ,  A61K9/08 ,  A61K47/34 ,  A61K47/32 ,  A61K47/26 ,  A61K47/06

CPC classification number: A61K31/401 ,  A61K9/0014 ,  A61K9/08 ,  A61K31/40 ,  A61K31/506 ,  A61K38/13 ,  A61K47/02 ,  A61K47/06 ,  A61K47/10 ,  A61K47/12 ,  A61K47/14 ,  A61K47/18 ,  A61K47/26 ,  A61K47/32 ,  A61K47/34 ,  A61N5/0617 ,  A61N2005/067 ,  A61K2300/00

Abstract: The present invention is directed to a composition for treating alopecia containing minoxidil, cyclosporine A and a compound that binds FK506 binding protein 4 suitable for administration to humans. The present invention is further directed to treating alopecia in humans by administering a composition of the invention.

公开(公告)号：US10709686B2

公开(公告)日：2020-07-14

申请号：US16358693

申请日：2019-03-20

Applicant: David Weinstein Consulting, Inc.

Inventor： David Weinstein

IPC: A61K31/40 ,  A61K9/00 ,  A61P11/00 ,  A61K38/13 ,  A61K31/401

Abstract: The present invention is related to a method of treating idiopathic pulmonary fibrosis comprising administering to a subject in need thereof an effective amount of a composition containing a compound that binds FK506 binding protein 4.

公开(公告)号：US20210100772A1

公开(公告)日：2021-04-08

申请号：US17124572

申请日：2020-12-17

Applicant: David Weinstein Consulting, Inc.

Inventor： David Weinstein

IPC: A61K31/401 ,  A61K38/13 ,  A61K31/506 ,  A61K31/40 ,  A61K47/10 ,  A61K47/18 ,  A61K47/14 ,  A61K47/12 ,  A61K47/02 ,  A61K9/00 ,  A61K47/06 ,  A61K47/26 ,  A61K47/32 ,  A61K47/34 ,  A61K9/08

Abstract: The present invention is directed to a method for simultaneously treating alopecia and achromotrichia comprising topically administering to a human in need thereof an effective amount of a composition comprising a compound of formula (II) or a pharmaceutically acceptable salt or ester thereof, minoxidil and cyclosporine A.

公开(公告)号：US20190290612A1

公开(公告)日：2019-09-26

申请号：US16358693

申请日：2019-03-20

Applicant: David Weinstein Consulting, Inc.

Inventor： David Weinstein

IPC: A61K31/40 ,  A61K9/00 ,  A61K38/13 ,  A61K31/401 ,  A61P11/00

Abstract: The present invention is related to a method of treating idiopathic pulmonary fibrosis comprising administering to a subject in need thereof an effective amount of a composition containing a compound that binds FK506 binding protein 4.

公开(公告)号：US10363240B2

公开(公告)日：2019-07-30

申请号：US15848628

申请日：2017-12-20

Applicant: David Weinstein Consulting, Inc.

Inventor： David Weinstein

IPC: A61K31/40 ,  A61K31/506 ,  A61K38/13 ,  A61K31/17 ,  A61K31/401 ,  A61N5/06 ,  A61N5/067

Abstract: The present invention is directed to a composition for treating alopecia containing minoxidil, cyclosporine A and a compound that binds FK506 binding protein 4 suitable for administration to humans. The present invention is further directed to treating alopecia in humans by administering a composition of the invention.

公开(公告)号：US20190216775A1

公开(公告)日：2019-07-18

申请号：US16356660

申请日：2019-03-18

Applicant: David Weinstein Consulting, Inc.

Inventor： David Weinstein

IPC: A61K31/40 ,  A61K38/13 ,  A61K31/401 ,  A61K31/506 ,  A61K31/17

CPC classification number: A61K31/40 ,  A61K31/17 ,  A61K31/401 ,  A61K31/506 ,  A61K38/13 ,  A61N5/0617 ,  A61N2005/067 ,  A61K2300/00

Abstract: The present invention is directed to a composition for treating alopecia containing minoxidil, cyclosporine A and a compound that binds FK506 binding protein 4 suitable for administration to humans. The present invention is further directed to treating alopecia in humans by administering a composition of the invention.

公开(公告)号：US10285977B2

公开(公告)日：2019-05-14

申请号：US15478547

申请日：2017-04-04

Applicant: David Weinstein Consulting, Inc.

Inventor： David Weinstein

IPC: A61K31/401 ,  A61K38/13 ,  A61K31/506 ,  A61K31/40 ,  A61K47/10 ,  A61K47/18 ,  A61K47/14 ,  A61K47/12 ,  A61K47/02 ,  A61K9/00 ,  A61K47/06 ,  A61K47/26 ,  A61K47/32 ,  A61K47/34 ,  A61K9/08 ,  A61N5/06 ,  A61N5/067

Abstract: The present invention is directed to a composition for treating alopecia containing minoxidil, cyclosporine A and a compound that binds FK506 binding protein 4 suitable for administration to humans. The present invention is further directed to treating alopecia in humans by administering a composition of the invention.